Cargando…
A TEST FOR ANTITHROMBIN IN THE BLOOD
A test is described for the estimation of antithrombin in the blood. The chief advantage of the test is that it is simple, and does not require the preparation of fibrinogen and of thrombin, which are difficult to prepare and to maintain in a pure state. The principle consists in titrating the antit...
Autor principal: | |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1915
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2125317/ https://www.ncbi.nlm.nih.gov/pubmed/19867876 |
_version_ | 1782141868388122624 |
---|---|
author | Hess, Alfred F. |
author_facet | Hess, Alfred F. |
author_sort | Hess, Alfred F. |
collection | PubMed |
description | A test is described for the estimation of antithrombin in the blood. The chief advantage of the test is that it is simple, and does not require the preparation of fibrinogen and of thrombin, which are difficult to prepare and to maintain in a pure state. The principle consists in titrating the antithrombin against normal human plasma; in this way we obtain an estimation of its power to delay coagulation. As the result of examinations carried out by this method, it would seem that there is a wide factor of safety as regards the amount of antithrombin in the human blood, and that this inhibiting substance may be increased to a considerable degree without markedly delaying or endangering clotting. |
format | Text |
id | pubmed-2125317 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1915 |
publisher | The Rockefeller University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-21253172008-04-18 A TEST FOR ANTITHROMBIN IN THE BLOOD Hess, Alfred F. J Exp Med Article A test is described for the estimation of antithrombin in the blood. The chief advantage of the test is that it is simple, and does not require the preparation of fibrinogen and of thrombin, which are difficult to prepare and to maintain in a pure state. The principle consists in titrating the antithrombin against normal human plasma; in this way we obtain an estimation of its power to delay coagulation. As the result of examinations carried out by this method, it would seem that there is a wide factor of safety as regards the amount of antithrombin in the human blood, and that this inhibiting substance may be increased to a considerable degree without markedly delaying or endangering clotting. The Rockefeller University Press 1915-04-01 /pmc/articles/PMC2125317/ /pubmed/19867876 Text en Copyright © Copyright, 1915, by The Rockefeller Institute for Medical Research New York This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/). |
spellingShingle | Article Hess, Alfred F. A TEST FOR ANTITHROMBIN IN THE BLOOD |
title | A TEST FOR ANTITHROMBIN IN THE BLOOD |
title_full | A TEST FOR ANTITHROMBIN IN THE BLOOD |
title_fullStr | A TEST FOR ANTITHROMBIN IN THE BLOOD |
title_full_unstemmed | A TEST FOR ANTITHROMBIN IN THE BLOOD |
title_short | A TEST FOR ANTITHROMBIN IN THE BLOOD |
title_sort | test for antithrombin in the blood |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2125317/ https://www.ncbi.nlm.nih.gov/pubmed/19867876 |
work_keys_str_mv | AT hessalfredf atestforantithrombinintheblood AT hessalfredf testforantithrombinintheblood |